Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography. An International, Multicenter, Prospective Development and Validation Trial.

NCT06266026 is registered in ClinicalTrials.gov with ThermoMind Ltd. as lead sponsor.

NCT NCT06266026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06266026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography. An International, Multicenter, Prospective Development and Validation Trial.
Lead sponsor
ThermoMind Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2023
Completion date
December 31, 2029
Enrollment
28,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer